shopify analytics ecommerce tracking
Chinese Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 401 - 420 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »

Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at the 2022 Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

Read more ››
By: GlobenewsWire - 07 Jan 2022
Related companies:  Mustang Investment Consulting (Shanghai) Co., Ltd. | Mustang Bio

Li Jian Quan, Chairman of WINNER MEDICAL Co., Ltd., Was Invited to "DIALOGUE PROGRAM" in CCTV-2 (China Central Television)

Read more ››
By: PR Newswire Association LLC. - 07 Jan 2022
Related companies:  Winner Medical Group Inc.

InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development

Read more ››
By: PR Newswire Association LLC. - 07 Jan 2022
Related companies:  InnoCare Pharma Limited

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Prominent Pain Clinic with Leading Physician

Read more ››
By: GlobenewsWire - 06 Jan 2022

Sino Biological Establishes New Location in Houston, Texas

Read more ››
By: GlobenewsWire - 06 Jan 2022

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH IVONESCIMAB (PD-1/VEGF BI-SPECIFIC ANTIBODY) COMBINED WITH OR WITHOUT CHEMOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF ADVANCED NON-SMALL

Read more ››
By: PR Newswire Association LLC. - 06 Jan 2022
Related companies:  Akeso, Inc.

Connect Biopharma Reports Detailed Positive Dataset from the Global Phase 2b Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis

Read more ››
By: GlobenewsWire - 05 Jan 2022
Related companies:  Suzhou Connect Biopharmaceuticals, Ltd. | Connect Biopharma Holdings Ltd.

Clover Doses First Participants with Homologous Booster Dose of COVID-19 Vaccine Candidate in SPECTRA

Read more ››
By: GlobenewsWire - 05 Jan 2022
Related companies:  Sichuan Clover Biopharmaceuticals, Inc.

Mustang Bio to Participate in Three January 2022 Virtual Investor Conferences

Read more ››
By: GlobenewsWire - 05 Jan 2022
Related companies:  Mustang Investment Consulting (Shanghai) Co., Ltd. | Mustang Bio

Clover Biopharmaceuticals Announces Construction of a New R&D Center in Zhangjiang Hi-Tech Park in Pudong Shanghai

Read more ››
By: GlobenewsWire - 05 Jan 2022
Related companies:  Sichuan Clover Biopharmaceuticals, Inc.

IND Approved for Pivotal Clinical Study of HER2 Bispecific Antibody KN026 Combined with Chemotherapy in Gastric Cancer

Read more ››
By: PR Newswire Association LLC. - 05 Jan 2022
Related companies:  Alphamab Oncology

Antengene to Present at the 40th Annual J.P. Morgan Healthcare Conference

Read more ››
By: PR Newswire Association LLC. - 05 Jan 2022
Related companies:  Antengene Corporation

Connect Biopharma to Host Conference Call on January 5 at 8:30 AM ET to Review Detailed Data from the Global Phase 2b Trial of CBP-201

Read more ››
By: GlobenewsWire - 04 Jan 2022
Related companies:  Suzhou Connect Biopharmaceuticals, Ltd. | Connect Biopharma Holdings Ltd.

Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group

Read more ››
By: GlobenewsWire - 04 Jan 2022
Related companies:  Apollomics, Inc. | Apollomics China

AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests and Will Start Clinical Trial in Q1, 2022

Read more ››
By: GlobenewsWire - 04 Jan 2022
Related companies:  Anpac Technology USA (Anpac Bio) | AnPac Bio-Medical Science Co., Ltd.

Chance Pharmaceuticals Completes Series C+ Funding to Advance Innovative Pipeline and Business Collaborations

Read more ››
By: GlobenewsWire - 04 Jan 2022
Related companies:  Hangzhou Chance Pharmaceuticals Co., Ltd.

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CONCURRENT CHEMORADIOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER

Read more ››
By: PR Newswire Association LLC. - 04 Jan 2022
Related companies:  Akeso, Inc.

Everest Medicines Announces Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer

Read more ››
By: PR Newswire Association LLC. - 04 Jan 2022
Related companies:  Everest Medicines (Shanghai)

Asieris Announces the World's First Patient Dose Administered in Combination of Asieris'APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients

Read more ››
By: PR Newswire Association LLC. - 04 Jan 2022
Related companies:  Asieris Pharmaceuticals

Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH

Read more ››
By: PR Newswire Association LLC. - 04 Jan 2022
Related companies:  Ascletis Pharma Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »

Looking for companies outside of China (Mainland)?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • May 2022
    • Pharma-Biotech Product & Company Valuation with Dr. P Frei
  • June 2022
    • Digital RESI
    • Product & Company Valuation Course
See Events »
Add an Event »

Latest company news

United Health Products Provides Regulatory Update
18 May 2022 (GlobenewsWire)

Antengene Announces XPOVIO® Treatment Regimens Included for the First Time in the Guidelines for the Diagnosis and Management of Multiple Myeloma in China
18 May 2022 (PR Newswire Association LLC.)

SIMCERE PHARMA (HK.2096) Novel Inhibitor of COVID-19 3CLpro SIM0417 Received a Second Clinical Trial Approval in China
18 May 2022 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The Chinese Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com